Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1999
08/03/1999US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents.
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932475 Human nucleolin-like protein
08/03/1999US5932471 DNA encoding chimeric toxin
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932469 Antimicrobial polypeptide, nucleic acid, and methods of use
08/03/1999US5932467 Genetic engineered cell
08/03/1999US5932448 Bispecific antibody heterodimers
08/03/1999US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present
08/03/1999US5932446 Hmvab41
08/03/1999US5932445 Signal peptide-containing proteins
08/03/1999US5932443 Human antigens
08/03/1999US5932442 Human regulatory molecules
08/03/1999US5932440 Mammalian ribonuclease inhibitors and use thereof
08/03/1999US5932439 Escherichia coli K-12 strains for production of recombinant proteins
08/03/1999US5932438 Preparation of thaumatin sweeteners
08/03/1999US5932427 In vitro assay system for identifying compositions useful for stimulating B cells
08/03/1999US5932426 Molecular presenting system
08/03/1999US5932425 Compositions and methods for modulating cellular NF-κB activation
08/03/1999US5932424 Screening compounds for binding sensitivity to peptide transport proteins in culture
08/03/1999US5932421 Methods and cell lines for identification of regulators of integrin activation
08/03/1999US5932420 Amplification by polymerase chain reaction
08/03/1999US5932417 Method of screening compounds for controlling capacitative calcium ion entry into mammalian cells
08/03/1999US5932415 Processes and agents for detecting listerias
08/03/1999US5932225 Vaccine comprising eimeria spp. gametocyte antigen
08/03/1999US5932224 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
08/03/1999US5932222 Mutant respiratory syncytial virus (RSV), vaccines containing same and methods of use
08/03/1999US5932220 Lyme disease; using a peptide
08/03/1999US5932219 Polypeptides
08/03/1999US5932218 Multideterminant peptides eliciting helper T-lymphocyte, cytotoxic T-lymphocyte, and neutralizing antibody responses against HIV-1
08/03/1999US5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells
08/03/1999US5932216 Antibodies to bone morphogenetic protein-10 (BMP-10)
08/03/1999US5932214 Treatment for inflammatory bowel disease with VLA-4 blockers
08/03/1999US5932210 Partial or total deletion of the adenoviral protein ix dna and having a gene encoding a foreign protein or a functional fragment or mutant thereof.
08/03/1999US5932209 Bacillus thuringiensis δ-endotoxin
08/03/1999US5932189 Radiotherapy, radiodiagnosis peptides
08/03/1999CA2093335C Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and composition
08/03/1999CA2017039C Gel filtration of heat treated factor viii
08/03/1999CA2002924C Anti-thrombins
08/03/1999CA1340689C Human b-cell differentiation factor and process of producing said factor
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999038014A1 Assessing risk for integrin antagonist/agonist mediated diseases
07/29/1999WO1999037821A1 Methods and compositions to investigate infection by hepatitis b virus and agents to prevent and treat the infection
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037812A1 Single nucleotide polymorphisms of the uncoupling protein 2 (ucp2) gene
07/29/1999WO1999037809A1 Asthma related genes
07/29/1999WO1999037803A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
07/29/1999WO1999037800A1 Antimicrobial compounds
07/29/1999WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof
07/29/1999WO1999037795A1 PROMOTER AND REGULATOR SEQUENCES Ha ds10 G1: A GENE LEA OF SUNFLOWER EXPRESSED EXCLUSIVELY IN SEEDS FROM THE MATURATION PHASE
07/29/1999WO1999037794A1 Methods and composition for modulating flavonoid content
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037784A1 Porcine reproductive and respiratory syndrome oral vaccine production in plants
07/29/1999WO1999037783A2 Live vaccine against brucellosis
07/29/1999WO1999037782A2 Frozen food product
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
07/29/1999WO1999037778A2 Compositions and methods for detecting and treating prostate cancer
07/29/1999WO1999037777A2 Differentiation-associated sequences and methods of use therefor
07/29/1999WO1999037776A1 Methods for modulating angiogenesis
07/29/1999WO1999037775A2 Compositions and methods for detecting and treating breast cancer
07/29/1999WO1999037774A2 Differentiation-associated sequences and methods of use therefor
07/29/1999WO1999037773A1 Acpl dna and polypeptides
07/29/1999WO1999037772A1 Il-18 receptors
07/29/1999WO1999037771A1 A new human tumor-associated gene
07/29/1999WO1999037770A1 Phagocytosis genes and uses thereof
07/29/1999WO1999037769A1 Orphan receptors
07/29/1999WO1999037768A1 Capon: a protein associated with neuronal nitric oxide synthase
07/29/1999WO1999037767A1 Novel collectin
07/29/1999WO1999037765A1 Human vanilloid receptor homologues
07/29/1999WO1999037764A2 New members of the glypican gene family
07/29/1999WO1999037763A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
07/29/1999WO1999037762A1 Trek-1 like two pore potassium channel
07/29/1999WO1999037761A1 Novel sequence variants of the human beta2-adrenergic receptor gene and use thereof
07/29/1999WO1999037759A2 Live attenuated salmonella vaccine
07/29/1999WO1999037758A2 Expression of proteolytically-sensitive peptides
07/29/1999WO1999037757A1 Cubilin protein, dna sequences encoding cubilin and uses thereof
07/29/1999WO1999037756A1 Non-human animal having a functionally disrupted slp-76 gene
07/29/1999WO1999037680A1 Purification of fibrinogen
07/29/1999WO1999037679A1 Ligand receptors and uses therefor
07/29/1999WO1999037678A2 Antimicrobial peptides
07/29/1999WO1999037677A1 Novel potassium channel protein
07/29/1999WO1999037676A1 Recombinant human mannan-binding proteins and process for producing the same
07/29/1999WO1999037675A1 Nucleic acid sequences encoding capsaicin receptors
07/29/1999WO1999037674A1 Secreted proteins and polynucleotides encoding them
07/29/1999WO1999037673A2 Antifreeze protein
07/29/1999WO1999037672A1 Method of screening for neuropharmaceuticals using the drosophila gene volado and its mutants
07/29/1999WO1999037671A1 Vegf related gene and protein
07/29/1999WO1999037670A1 Synthetic polymers and methods, kits or compositions for modulating the solubility of same
07/29/1999WO1999037669A1 PEPTIDES WITH β1 INTEGRIN SUBUNIT DEPENDENT CELL ADHESION MODULATING ACTIVITY
07/29/1999WO1999037665A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
07/29/1999WO1999037664A1 Novel peptides having biological activity
07/29/1999WO1999037662A1 Spoil protein and nucleic acid molecules and uses therefor
07/29/1999WO1999037661A1 Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
07/29/1999WO1999037660A1 Meth1 and meth2 polynucleotides and polypeptides
07/29/1999WO1999037659A1 Identification and expression of a novel kinesin motor protein
07/29/1999WO1999037331A1 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
07/29/1999WO1999037330A1 Method for determining gene essentiality in a pathogen
07/29/1999WO1999037326A1 Biologically active hemagglutinin from type a clostridium botulinum and methods of use
07/29/1999WO1999037317A1 Artificial proteoglycans
1 ... 2262 2263 2264 2265 2266 2267 2268 2269 2270 2271 2272 2273 2274 2275 2276 2277 2278 2279 2280 2281 2282 ... 2916